Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 47 of 114, showing 5 Applications out of 567 total, starting on record 231, ending on 235

# Protocol No Study Title Investigator(s) & Site(s)

231.

ECCT/20/10/03   Commercial Typhoid tests valid
    Comparative study of commercially available typhoid point of care tests to benchmark current and emerging tools   
Principal Investigator(s)
1. Robert Sanaya Onsare
Site(s) in Kenya
1. Mbagathi County Hospital (Nairobi City county)
2. Medical Missionaries of Mary, Reuben Centre Hospital, Mukuru (Nairobi City county)
3. City Council Clinic, Mukuru (Nairobi City county)
 
View

232.

ECCT/08/27/12   MAL 55: A phase III, double blind (observer-blind), randomised, controlled multicenter study to evaluate, in infants and children, the efficacy of the RTS,S/AS01E candidate vaccine against malaria disease caused by P. falciparum infection.
    Protocol No. 110021 - MAL 55 STUDY   A phase III, double blind (observer-blind), randomised, controlled multicenter study to evaluate, in infants and children, the efficacy of the RTS,S/AS01E candidate vaccine against malaria disease caused by P. falciparum infection, across diverse malaria transmission settings in Africa”   
Principal Investigator(s)
1. Dr. Mary Hamel
2. Dr. Patricia Njuguna
3. Dr. Walter Otieno
Site(s) in Kenya
1. KEMRI - CDC RESEARCH INSTITUTION CENTRE, KISUMU (Kisumu county)
2. KEMRI-WELLCOME TRUST RESEARCH CENTER, KILIFI SITE (Kilifi county)
3. KEMRI-WALTERREED, RESEARCH CENTRE, KOMBEWA SITE (Kisumu county)
 
View

233.

ECCT/19/03/02   PREVENT TD
    A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550 mg daily or 550 mg twice daily) for Chemoprophylaxis Against Travellers’ Diarrhoea (TD) Among Active Duty Deployed U.S. and British Military Personnel (PREVENT TD)   
Principal Investigator(s)
1. Flynn Alexander
Site(s) in Kenya
Nyati Barracks, British Army Training Unit, Kenya
 
View

234.

ECCT/21/09/03   Women TDF/FTC Benchmark Study
    Pharmacology of TDF-FTC Pre-exposure Prophylaxis in Kenyan Cisgender Women   
Principal Investigator(s)
1. Nelly Mugo
Site(s) in Kenya
KEMRI-CCR PHRD (THIKA) PROJECT
 
View

235.

ECCT/16/10/01   INVICTUS
    INVESTIGATION OF RHEUMATIC AF TREATMENT USING VITAMIN K ANTAGONISTS, RIVAROXABAN OR ASPRIN STUDIES   
Principal Investigator(s)
1. Elijah Nyainda Ogola
2. felix ayub barasa
Site(s) in Kenya
1. Kenyatta National hospital (Nairobi City county)
2. Moi teaching and Referral Hospital (Uasin Gishu county)
3. The Karen Hospital (Nairobi City county)
 
View